MAM
Nargis Fakhri is brand ambassador for Van Heusen Woman
BANGALORE: Van Heusen has roped in Bollywood debutante Nargis Fakhri as the brand ambassador for its women‘s range of fashion wear – Van Heusen Woman.
Fakhri, who recently burst on to the Bollywood scene with the movie Rockstar, has been a New York based model. In her first campaign for Van Heusen Woman, Fakhri will feature in the brand‘s range of dresses which is the centre piece of the Autumn-Winter season.
A Van Heusen source says, “Nargis‘ choice as a brand ambassador for Van Heusen Woman brings together key values that work in tandem. The brand is on the cusp of a steep growth and is well poised to extend its appeal to a large western-wear sporting audience, while Nargis‘s career is set to take off equally well.”
Shot by internationally acclaimed photographer Justin Polkey, the campaign sees Fakhri as a go-getter with a wardrobe to boot. She will be seen in lace sheath, stripes, animal prints, florals, paired with unlined blazers, parka jackets, suede coats, offset by oversized belts and maxi envelope clutches.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
